These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15492787

  • 21. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K, Pushparaj V, Biswas J, Krishnakumar S.
    Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948
    [Abstract] [Full Text] [Related]

  • 22. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K, Nakamura T, Sakai K, Nakamura T.
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [Abstract] [Full Text] [Related]

  • 23. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
    Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E.
    Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
    [Abstract] [Full Text] [Related]

  • 24. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
    Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He WL, Xu JB, Zan WH.
    J Surg Oncol; 2012 Sep 01; 106(3):304-10. PubMed ID: 22231933
    [Abstract] [Full Text] [Related]

  • 25. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
    Miyata Y, Sagara Y, Kanda S, Hayashi T, Kanetake H.
    Hum Pathol; 2009 Apr 01; 40(4):496-504. PubMed ID: 19121849
    [Abstract] [Full Text] [Related]

  • 26. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
    Shi BB, Zhang XH, Wang HJ, Li HZ.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 01; 26(6):356-8. PubMed ID: 15312347
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis.
    Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao MS.
    Am J Pathol; 1995 Oct 01; 147(4):889-95. PubMed ID: 7573364
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
    Osada S, Matsui S, Komori S, Yamada J, Sanada Y, Ihawa A, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, Hosono Y, Takahashi T, Yamaguchi K, Yoshida K.
    Hepatogastroenterology; 2010 Oct 01; 57(97):76-80. PubMed ID: 20422876
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Expression and localization of HGF and met in Wilms' tumours.
    Alami J, Williams BR, Yeger H.
    J Pathol; 2002 Jan 01; 196(1):76-84. PubMed ID: 11748645
    [Abstract] [Full Text] [Related]

  • 34. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL, Wu CW.
    Eur J Surg Oncol; 2008 Mar 01; 34(3):333-8. PubMed ID: 17218078
    [Abstract] [Full Text] [Related]

  • 35. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.
    Wislez M, Rabbe N, Marchal J, Milleron B, Crestani B, Mayaud C, Antoine M, Soler P, Cadranel J.
    Cancer Res; 2003 Mar 15; 63(6):1405-12. PubMed ID: 12649206
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
    Trovato M, Vitarelli E, Grosso M, Alesci S, Benvenga S, Trimarchi F, Barresi G.
    Eur J Histochem; 2004 Mar 15; 48(3):291-7. PubMed ID: 15590419
    [Abstract] [Full Text] [Related]

  • 39. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
    Miyata Y, Kanetake H, Kanda S.
    Clin Cancer Res; 2006 Aug 15; 12(16):4876-81. PubMed ID: 16914575
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.